Document evM4ByErkx9jDqbVzGNz0EK09

OUTLINE OF 0 8 BLOOD SAMPLING PROGRAM Sigi. The sampling program to determine levels of C-8 in employees' blood has several purposes. These are listed below in order of priority. It is felt that an overall communication of intent of program would have a negative impact at this time. Blood sampling as an "overall" program has already been covered in the April 1 communication to employe.es. Pregnant Females - W ashington Works Provide information for physician to use to counsel or reassure about possible pregnancy outcome. Physician's statement and Q & A required (see next page). Prepared by 4/20. Data available for dis cussing with employees by 4/20. Nonpregnant Females - Washington Works Provide information that the physician can use to advise females on pregnancy planning. Physician's statement, Q & A , and data available 4/20 (see next page). Sampling at Germay Park, Circleville, etc. To confirm previous assessment of exposure for females. Statement and Q & A to be prepared by 4/27. Sampling start __________ . Sampling of Males at Germay Park To be included to confirm background level. Washington Works - Males Provide information on decay rate of C-8. Sampling in progress. Washington Works - Various Groups Provide data for pregnancy outcome study and confirm background level. Communications bo be included in that for epidemiology study if decision is made to proceed, .... . EID090073 AJP002935 1 000057 WASHINGTON WORKS OUTLINE OF EMPLOYEE COMMUNICATIONS BLOOD SAMPLING PROGRAM In order of priority: Inform females removed from Teflon of their blood results - by plant doctor in private. To do: develop Q&A for doctor to advise: (A) those with blood levels below "background" of 0.4 ppm. (B) those with blood levels above background. (C) those in (A) and (B) who are pregnant. (D) those in (A) and (B) who de sire advice on future preg nancies . (E) effects of blood level on over all health of individual. (F) those who may wish to consult their, physiciati. When: Target Date - approved Q&A - 4/20/81 Inform males of recent blood sampling results. To do: existing communication procedures are adequate. When: Ongoing. EID090074 AJP002936 000058 'OTOETR EMPLbYEE MMUNIfcATiONS ' " ' Introduce and encourage support for the "pregnancy out- cqme" study. To D o : (a) Communicate study objectives. (b) Communicate employee participation. When: Prior to study. Update evaluation of blood level results: To D o : Define trends for those still in Teflon Division. Define decay rate for those no longer exposed. Possible redefinition of "back ground" levels. Update Haskell (and 3M) animal test program. To do: Define new studies - objectives and timing.' Note: Items 3, 4 and 5 could be combined in one package. AJP002937 L. F. Percival 4/14/81 EID090075 000059 TO: H. G. SMYTH FROM: BURFORD W. CULPEPPER, CC: ERD Division Directors F. W. Rappaport - N-13519 J. C. Bonnett, M.D. B. W. Karrh, M.D. WEEKLY NOTES April 28, 1981 C-8 (FC-143) C-8 (FC-143) blood level testing continues with exposed employees and controls recruited from the Corporate headquarters. 13 controls tested thus far have had non-detectable levels of C-8? i.e.,< 0.004 ppm. Haskell has initiated an animal study this week that may help deter mine a "no-effect" level in rats. Results will not be available for 60 days. In the interim, our standard of 0.-0.4 ppm total organic fluorides will continue to be used as a blood level that will not mandate removal of females from the workplace. BWC:ceb EID096481 000060 BWK000121